ClinicalTrials.gg
RecruitingNCT06843512Updated Sep 10, 2025

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

An observational study in Weight Loss and Food Selection, sponsored by Penn State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-10.

Primary conditionFood PreferencesRegistry: Weight LossReclassifiedWhy we changed it
Registry
Weight Loss — the first condition term the registry derived for this study.
ClinicalTrials.gg
Food Preferences
Why
  1. Weight Loss is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Food Preferences.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Penn State University · Observational

How we know

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
25
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 62 studies in Food Preferences with a site in United States — 8 open to participants now, 8 under way, none of them phase 3. Food Preferences · United States.

Started
2025
with 7 others
Observational
7 of 62
1 open now
Registered
54th of 62
by date
Lead sponsor
2 of 62
Penn State University

Among the 62 studies in Food Preferences with a site in United States, this one is one of 8 that started in 2025, is one of 7 observational ones, and was the 54th registered.

Food Preferences

155 studies on the registry are indexed under Food Preferences; 19 are open to participants now.

Browse Food Preferences studies →

Open to participants now

8 of the 62 studies in Food Preferences with a site in United States are open now. Recruiting first, the newest first:

2 more — sign in →

All 8 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 15 Food Preferences studies recruiting now, 2 (13%) set no upper age limit and 12 (80%) stop at 75 or younger; 5 take children under 18; 12 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 62 studies in Food Preferences with a site in United States, or all of them as a file.
02

Study summary

In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.

03

Conditions studied

  • Weight Loss
  • Food Selection

Browse trials for

Keywords

  • GLP-1
  • Weight Loss
  • Virtual Reality
  • Food behavior
04

In context

Food Preferences Reclassified

155 studies on the registry are indexed under Food Preferences; 19 are open to participants now.

This study's planned enrollment of 25 is below the median of 80 across 34 observational studies indexed under Food Preferences.

Browse Food Preferences studies →

Lead sponsor

Penn State University is the lead sponsor of 271 studies on the registry; 54 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 11 (73%) have results posted.

Compared within Food Preferences, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Weight Loss. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants will be identified from a list of medical patients prescribed GLP-1 medication by their physicians (located in offices near State College or Hershey, PA) and who volunteered to be contacted regarding studies they are eligible for.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (18+) with overweight or obesity ( >25 kg/m2)
  • Not currently taking an incretin-based medication at baseline
  • Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)
  • Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
  • Fluent in English

Exclusion criteria

Exclusion Criteria:

  • Adults (18+) without overweight or obesity
  • \<18 years of age at time of testing
  • Adults not taking a GLP-1 Medication
  • Adults taking a compound GLP-1
  • Adults on GLP-1 medication for longer than 2 weeks at baseline
  • Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.
  • Not fluent in English
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
25 participants (estimated)
Patient registry
No

Interventions

  • OtherGLP-1 Medication Initiation

    One visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits.

07

What researchers measure

Primary outcomes

  1. Change from Baseline in Total Weight of Food Selected in the VR Buffet at 3 Months

    Time frame: Baseline and 3 months

  2. Change from Baseline in Total Calories of Food Selected in the VR Buffet at 3 Months

    Time frame: Baseline and 3 months

  3. Change from Baseline in Energy Density of Food Selected in the VR Buffet at 3 Months

    Time frame: Baseline and 3 months

  4. Change from Baseline in Variety of Food Selected in the VR Buffet at 3 Months

    Time frame: Baseline and 3 months

Secondary outcomes

  1. Change in Baseline Weight Watchers Food Noise Score at 3 Months

    Based on participant's answers to the WW Food Noise questionnaire; Scale of 1-5, 1 being strongly disagree and 5 being strongly agree; Higher scores mean more food noise

    Time frame: Baseline and 3 months

  2. Change in Baseline 9-question External Food Cue Responsiveness Questionnaire Score at 3 Months

    Answers are on a 1-4 scale with 1 being "Rarely" and 4 being "A lot"; higher scores suggest more external food cue reactivity

    Time frame: Baseline and 3 months

  3. Change in Baseline Adult Eating Behavior Score at 3 Months

    Answers on a 1-5 scale with 1 being "Strongly disagree" and 5 being "Strongly agree"; 8 subscales, high scores indicate greater expression of subscale measure

    Time frame: Baseline and 3 months

  4. Change in Baseline Three-Factor Eating Questionnaire Score at 3 Months

    Rated on a scale of 1-4 with 1 being "Definitely false" and 4 being "Definitely true"; 3 subscales, higher scales on each means greater expression of that behavior

    Time frame: Baseline and 3 months

  5. Change in Baseline General Food Craving-Trait Scale Score at 3 Months

    Rated on a 0-5 scale with 0 being "Never/not applicable" and 5 being "Always"; higher scores mean more food dependent

    Time frame: Baseline and 3 months

  6. Change in Baseline Buffet Food Liking Scores at 3 Months

    Rated on a 0-100 scale with 0 being "Dislike extremely" and 100 being "Like extremely"; high scores mean greater liking of the food

    Time frame: Baseline and 3 months

Other outcomes

  1. Change in Baseline BMI at 3 Months

    Calculated from height and weight collected at the end of both sessions

    Time frame: Baseline and 3 months

08

Study locations

1 of 1 sites recruiting
  • Health, Ingestive Behavior, and Technology Laboratory of Pennsylvania State University
    State College, Pennsylvania 16802, United States
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Dec 2026, 17 months after the start.

Of 13 observational studies under Food Preferences, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 43. This study's planned 17 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 20, 2025
First posted
Feb 25, 2025
StartActual
Jul 15, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Sep 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT06843512
Responsible party
Travis Masterson (Assistant Professor and Director of the Health, Ingestive Behavior, and Technology Lab, Penn State University) — Principal investigator
First posted
Feb 25, 2025
Start date
Jul 15, 2025
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Sep 10, 2025

Study contacts

Christina M Blackmon
Contact
cmb8633@psu.edu
425-499-8049
Travis Masterson
principal investigator · The Pennsylvania State University

Oversight

FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion